ArticleCost effectiveness and resource allocation : C/E2025
Early versus delayed enteral nutrition in critically ill children under 12 years of age: an economic evaluation.
Article in Cost effectiveness and resource allocation : C/E, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Factors that influence the provision of enteral feeding for critically ill children: a qualitative evidence synthesis.BMC nutrition · 2025Pooled it
- Oral iron supplementation as a public health intervention in children aged 6 to 23 months for preventing iron deficiency and anaemia: Economic evaluation for the South African health system.African journal of primary health care & family medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionNutritional support is an integral part of treating critically ill children in paediatric intensive care units (PICUs). Early enteral nutrition (EEN) in the PICU has been shown to have greater benefits compared to delayed enteral nutrition (DEN) in reducing PICU and hospital stays and lowering mortality. In this study, we conducted a cost comparison and cost-effectiveness analysis of early versus delayed enteral nutrition during PICU and hospital stays for children aged 1 month to 12 years in Malawi.
methodsWe used primary and secondary data to cost PICU and hospital admissions from a payer perspective. We developed a stochastic model that assumed that equal cohorts of 500 critically ill children were admitted to the PICU and provided with EEN and DEN. Using the average length of stay in the PICU and hospital and cost data, we estimated total cohort costs and the average cost per patient for each strategy. We estimated disability-adjusted life years (DALYs) and used the total hospital costs to estimate the incremental cost-effectiveness ratio (ICER). Deterministic and probabilistic sensitivity analyses were conducted to assess the robustness of the results.
resultsThe total cohort cost for EEN in the PICU was lower, $479,850, than that for DEN, $515,623. The total cohort costs for the hospital stay were also lower for EEN, $564,290, than for DEN, $613,902. The average cost per patient for EEN in the PICU was lower at $960 than $1031 for DEN. The average cost per patient for the hospital was also lower for EEN, $1129, than for DEN, $1228. EEN dominated DEN and the ICER was estimated as -$39.47/DALY averted. Probabilistic sensitivity analysis showed that EEN had a greater probability of being cost-effective, for a capacity to pay or cost-effectiveness threshold range of 0$-2000$/DALY averted, than DEN. Scaling up the implementation of EEN led to higher net monetary and health benefits.
conclusionEEN in children aged 1 month to 12 years was found to be less costly and more cost-effective than DEN in Malawi.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.